DRUG · Unmapped registry intervention
CKD-386
Find medicine records ·
Find other trials using this name
Clinical trial
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386
NCT04673864
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
D012, D326, D337
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Hypertension and Dyslipidemiaunresolved
Interventions
CKD-386DRUG
D012, D326, D337DRUG
Sponsors & collaborators
Chong Kun Dang Pharmaceuticallead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04673864 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.